Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

European Commission, IMF officials weigh in on shadow banking

Monday, September 16, 2013

Bailey McCann, Opalesque New York:

International bodies are weighing in on shadow banking. Last week, the European Commission released its roadmap for how it plans to handle risk from shadow banking activities and today, an IMF official in China said that shadow banking in China will not cause a collapse of that economy despite risks. Both moves may bolster the alternatives industry as more and more firms enter the speciality finance space.

The European Commission has plans to reform how it monitors shadow banking activities. The roadmap is far-reaching and detailed in terms of how it sees the space and what it plans to do. The plan takes a fivefold approach to regulating shadow banking, making for a process that will be lengthy and heavily lobbied. The Commission has valued the global shadow banking industry in 2010 at €51 trillion, and says that its goal in regulation is to build investor trust and confidence.

The five point plan came a week after the Financial Stability Board issued its Final Policy Recommendations and reaffirms many of those definitions and guidelines. However, shortly after the plan was introduced several EU member states including Germany expressed dissatisfaction with the plan saying the proposed regulations didn't go far enough. Presumably, only when all liquidity is gone from the markets will participants be sufficiently supervised.

Law firm Clifford Chance ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its